{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,12]],"date-time":"2025-10-12T04:37:57Z","timestamp":1760243877686,"version":"build-2065373602"},"reference-count":82,"publisher":"MDPI AG","issue":"1","license":[{"start":{"date-parts":[[2010,1,22]],"date-time":"2010-01-22T00:00:00Z","timestamp":1264118400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/3.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Viruses"],"abstract":"<jats:p>It is well known that mucosal tissues contain the largest surface area of the human body and are the front line of natural host defense against various pathogens. In fact, more than 80% of infectious disease pathogens probably gain entry into the susceptible human hosts through open mucosal surfaces. Human immunodeficiency virus type one (HIV-1), a mainly sexually transmitted virus, also primarily targets the vaginal and gastrointestinal mucosa as entry sites for viral transmission, seeding, replication and amplification. Since HIV-1 establishes its early replication in vaginal or rectal mucosal tissues, the induction of sufficient mucosal immunity at the initial site of HIV-1 transmission becomes essential for a protective vaccine. However, despite the fact that current conventional vaccine strategies have remained unsuccessful in preventing HIV-1 infection, sufficient financial support and resources have yet to be given to develop a vaccine able to elicit protective mucosal immunity against sexual transmissions. Interestingly, Chinese ancestors invented variolation through intranasal administration about one thousand years ago, which led to the discovery of a successful smallpox vaccine and the final eradication of the disease. It is the hope for all mankind that the development of a mucosal AIDS vaccine will ultimately help control the AIDS pandemic. In order to discover an effective mucosal AIDS vaccine, it is necessary to have a deep understanding of mucosal immunology and to test various mucosal vaccination strategies.<\/jats:p>","DOI":"10.3390\/v2010283","type":"journal-article","created":{"date-parts":[[2010,1,25]],"date-time":"2010-01-25T02:53:55Z","timestamp":1264388035000},"page":"283-297","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["The Development of an AIDS Mucosal Vaccine"],"prefix":"10.3390","volume":"2","author":[{"given":"Xian","family":"Tang","sequence":"first","affiliation":[{"name":"AIDS Institute, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong SAR, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhiwei","family":"Chen","sequence":"additional","affiliation":[{"name":"AIDS Institute, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong SAR, China"},{"name":"Department of Microbiology and Research Center of Infection and Immunology, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong SAR, China"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2010,1,22]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/S0171-2985(11)80473-0","article-title":"Mucosal immunity: implications for vaccine development","volume":"184","author":"Holmgren","year":"1992","journal-title":"Immunobiology"},{"key":"ref_2","first-page":"174","article-title":"Gastrointestinal manifestations of HIV infection","volume":"32","author":"Schneider","year":"1994","journal-title":"Zeitschrift fuer Gastroenterologie"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"S45","DOI":"10.1038\/nm1213","article-title":"Mucosal immunity and vaccines","volume":"11","author":"Holmgren","year":"2005","journal-title":"Nat. Med."},{"key":"ref_4","unstructured":"Mestecky, J. (2005). Elsevier Academic Press. [3rd]."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1111\/j.1365-2036.1997.tb00806.x","article-title":"Review article: Homing of mucosal immune cells--a possible connection between intestinal and articular inflammation","volume":"11","author":"Brandtzaeg","year":"1997","journal-title":"Aliment. Pharmacol. Ther."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1038\/nri1203","article-title":"Plasma-cell homing","volume":"3","author":"Kunkel","year":"2003","journal-title":"Nat. Rev. Immunol."},{"key":"ref_7","unstructured":"Paul, W.E. (2003). Lippincott Williams & Wilkins. [5th]."},{"key":"ref_8","unstructured":"Paul, W.E. (2008). Wolters Kluwer\/Lippincott Williams & Wilkins. [6th]."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"1521","DOI":"10.1001\/jama.1960.03020320001001","article-title":"Live, orally given poliovirus vaccine. Effects of rapid mass immunization on population under conditions of massive enteric infection with other viruses","volume":"173","author":"Sabin","year":"1960","journal-title":"JAMA"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/S0042-6822(02)00035-1","article-title":"Multiple amino acid residues confer temperature sensitivity to human influenza virus vaccine strains (FluMist) derived from cold-adapted A\/Ann Arbor\/6\/60","volume":"306","author":"Jin","year":"2003","journal-title":"Virology"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"2151","DOI":"10.1016\/j.vaccine.2005.11.007","article-title":"Genetic stability of live, cold-adapted influenza virus components of the FluMist\/CAIV-T vaccine throughout the manufacturing process","volume":"24","author":"Buonagurio","year":"2006","journal-title":"Vaccine"},{"key":"ref_12","first-page":"1","article-title":"Using live, attenuated influenza vaccine for prevention and control of influenza: supplemental recommendations of the Advisory Committee on Immunization Practices (ACIP)","volume":"52","author":"Harper","year":"2003","journal-title":"MMWR Recomm. Rep."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"9307","DOI":"10.1128\/JVI.72.11.9307-9312.1998","article-title":"Chemokine coreceptor usage by diverse primary isolates of human immunodeficiency virus type 1","volume":"72","author":"Zhang","year":"1998","journal-title":"J. Virol."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"2705","DOI":"10.1128\/jvi.71.4.2705-2714.1997","article-title":"Genetically divergent strains of simian immunodeficiency virus use CCR5 as a coreceptor for entry","volume":"71","author":"Chen","year":"1997","journal-title":"J. Virol."},{"key":"ref_15","first-page":"245","article-title":"The mucosal immune system and HIV-1 infection","volume":"5","author":"Veazey","year":"2003","journal-title":"AIDS Rev"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"1726","DOI":"10.1126\/science.1168676","article-title":"Visualizing antigen-specific and infected cells in situ predicts outcomes in early viral infection","volume":"323","author":"Li","year":"2009","journal-title":"Science"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1126\/science.280.5362.427","article-title":"Gastrointestinal tract as a major site of CD4+ T cell depletion and viral replication in SIV infection","volume":"280","author":"Veazey","year":"1998","journal-title":"Science"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"1965","DOI":"10.1053\/j.gastro.2008.12.071","article-title":"The gastrointestinal tract and AIDS pathogenesis","volume":"136","author":"Lackner","year":"2009","journal-title":"Gastroenterology"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1126\/science.284.5415.816","article-title":"Distinct pathogenic sequela in rhesus macaques infected with CCR5 or CXCR4 utilizing SHIVs","volume":"284","author":"Harouse","year":"1999","journal-title":"Science"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1097\/00042560-200206010-00001","article-title":"CD4+ lymphocytopenia in acute infection of Asian macaques by a vaginally transmissible subtype-C, CCR5-tropic Simian\/Human Immunodeficiency Virus (SHIV)","volume":"30","author":"Chen","year":"2002","journal-title":"J. Acquir. Immune Defic. Syndr."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1084\/jem.20040874","article-title":"CD4+ T cell depletion during all stages of HIV disease occurs predominantly in the gastrointestinal tract","volume":"200","author":"Brenchley","year":"2004","journal-title":"J. Exp. Med."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1084\/jem.20041196","article-title":"Primary HIV-1 infection is associated with preferential depletion of CD4+ T lymphocytes from effector sites in the gastrointestinal tract","volume":"200","author":"Mehandru","year":"2004","journal-title":"J. Exp. Med."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.1126\/science.286.5443.1353","article-title":"Sexual transmission and propagation of SIV and HIV in resting and activated CD4+ T cells","volume":"286","author":"Zhang","year":"1999","journal-title":"Science"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1084\/jem.183.1.215","article-title":"Cellular targets of infection and route of viral dissemination after an intravaginal inoculation of simian immunodeficiency virus into rhesus macaques","volume":"183","author":"Spira","year":"1996","journal-title":"J. Exp. Med."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1086\/315776","article-title":"Estrogen protects against vaginal transmission of simian immunodeficiency virus","volume":"182","author":"Smith","year":"2000","journal-title":"J. Infect. Dis."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"9217","DOI":"10.1128\/JVI.79.14.9217-9227.2005","article-title":"Propagation and dissemination of infection after vaginal transmission of simian immunodeficiency virus","volume":"79","author":"Miller","year":"2005","journal-title":"J. Virol."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1084\/jem.20090378","article-title":"Genetic identity, biological phenotype, and evolutionary pathways of transmitted\/founder viruses in acute and early HIV-1 infection","volume":"206","author":"Salazar","year":"2009","journal-title":"J. Exp. Med."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"7552","DOI":"10.1073\/pnas.0802203105","article-title":"Identification and characterization of transmitted and early founder virus envelopes in primary HIV-1 infection","volume":"105","author":"Keele","year":"2008","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1038\/nature03501","article-title":"Massive infection and loss of memory CD4+ T cells in multiple tissues during acute SIV infection","volume":"434","author":"Mattapallil","year":"2005","journal-title":"Nature"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"1148","DOI":"10.1038\/nature03513","article-title":"Peak SIV replication in resting memory CD4+ T cells depletes gut lamina propria CD4+ T cells","volume":"434","author":"Li","year":"2005","journal-title":"Nature"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"588","DOI":"10.2174\/157016207782418452","article-title":"Neutralizing antibodies in mucosal secretions: IgG or IgA?","volume":"5","author":"Alexander","year":"2007","journal-title":"Curr. HIV Res."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"1917","DOI":"10.1097\/00002030-200009080-00006","article-title":"Mucosal and plasma IgA from HIV-exposed seronegative individuals neutralize a primary HIV-1 isolate","volume":"14","author":"Devito","year":"2000","journal-title":"Aids"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1097\/00042560-200208010-00007","article-title":"Cross-clade HIV-1-specific neutralizing IgA in mucosal and systemic compartments of HIV-1-exposed, persistently seronegative subjects","volume":"30","author":"Devito","year":"2002","journal-title":"J. Acquir. Immune Defic. Syndr."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/S0165-2478(01)00263-2","article-title":"Functional HIV-1 specific IgA antibodies in HIV-1 exposed, persistently IgG seronegative female sex workers","volume":"79","author":"Broliden","year":"2001","journal-title":"Immunol. Lett."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1038\/mi.2009.89","article-title":"HIV-1 gp41-specific monoclonal mucosal IgAs derived from highly exposed but IgG-seronegative individuals block HIV-1 epithelial transcytosis and neutralize CD4(+) cell infection: an IgA gene and functional analysis","volume":"2","author":"Tudor","year":"2009","journal-title":"Mucosal Immunol."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1097\/00002030-200006160-00008","article-title":"Absence of specific mucosal antibody responses in HIV-exposed uninfected sex workers from the Gambia","volume":"14","author":"Dorrell","year":"2000","journal-title":"Aids"},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"1637","DOI":"10.1086\/522232","article-title":"Mucosal HIV-binding antibody and neutralizing activity in high-risk HIV-uninfected female participants in a trial of HIV-vaccine efficacy","volume":"196","author":"Schneider","year":"2007","journal-title":"J. Infect. Dis."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"4825","DOI":"10.1182\/blood-2005-06-2463","article-title":"Long-lasting CCR5 internalization by antibodies in a subset of long-term nonprogressors: a possible protective effect against disease progression","volume":"107","author":"Pastori","year":"2006","journal-title":"Blood"},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"1978","DOI":"10.4049\/jimmunol.173.3.1978","article-title":"Role of IgA versus IgG in the control of influenza viral infection in the murine respiratory tract","volume":"173","author":"Renegar","year":"2004","journal-title":"J. Immunol."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"4095","DOI":"10.1128\/JVI.77.7.4095-4103.2003","article-title":"Characterization of human class-switched polymeric (immunoglobulin M [IgM] and IgA) anti-human immunodeficiency virus type 1 antibodies 2F5 and 2G12","volume":"77","author":"Wolbank","year":"2003","journal-title":"J. Virol."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1038\/nm.1974","article-title":"Effective, low-titer antibody protection against low-dose repeated mucosal SHIV challenge in macaques","volume":"15","author":"Hessell","year":"2009","journal-title":"Nat. Med."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"e1000433:1","DOI":"10.1371\/journal.ppat.1000433","article-title":"Broadly neutralizing human anti-HIV antibody 2G12 is effective in protection against mucosal SHIV challenge even at low serum neutralizing titers","volume":"5","author":"Hessell","year":"2009","journal-title":"PLoS Pathog."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1084\/jem.189.6.991","article-title":"Dramatic rise in plasma viremia after CD8(+) T cell depletion in simian immunodeficiency virus-infected macaques","volume":"189","author":"Jin","year":"1999","journal-title":"J. Exp. Med."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1126\/science.283.5403.857","article-title":"Control of viremia in simian immunodeficiency virus infection by CD8+ lymphocytes","volume":"283","author":"Schmitz","year":"1999","journal-title":"Science"},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1084\/jem.20090365","article-title":"The first T cell response to transmitted\/founder virus contributes to the control of acute viremia in HIV-1 infection","volume":"206","author":"Goonetilleke","year":"2009","journal-title":"J. Exp. Med."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"13348","DOI":"10.1128\/JVI.77.24.13348-13360.2003","article-title":"Multispecific vaccine-induced mucosal cytotoxic T lymphocytes reduce acute-phase viral replication but fail in long-term control of simian immunodeficiency virus SIVmac239","volume":"77","author":"Vogel","year":"2003","journal-title":"J. Virol."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"2400","DOI":"10.1128\/JVI.77.4.2400-2409.2003","article-title":"Mucosal priming of simian immunodeficiency virus-specific cytotoxic T-lymphocyte responses in rhesus macaques by the Salmonella type III secretion antigen delivery system","volume":"77","author":"Evans","year":"2003","journal-title":"J. Virol."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"11484","DOI":"10.1128\/JVI.76.22.11484-11490.2002","article-title":"Elicitation of simian immunodeficiency virus-specific cytotoxic T lymphocytes in mucosal compartments of rhesus monkeys by systemic vaccination","volume":"76","author":"Baig","year":"2002","journal-title":"J. Virol."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"11659","DOI":"10.1128\/JVI.76.22.11659-11676.2002","article-title":"Both mucosal and systemic routes of immunization with the live, attenuated NYVAC\/simian immunodeficiency virus SIV(gpe) recombinant vaccine result in gag-specific CD8(+) T-cell responses in mucosal tissues of macaques","volume":"76","author":"Stevceva","year":"2002","journal-title":"J. Virol."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"1602","DOI":"10.4049\/jimmunol.164.3.1602","article-title":"HIV-1-specific mucosal CD8+ lymphocyte responses in the cervix of HIV-1-resistant prostitutes in Nairobi","volume":"164","author":"Kaul","year":"2000","journal-title":"J. Immunol."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"4289","DOI":"10.1128\/JVI.79.7.4289-4297.2005","article-title":"Parallel human immunodeficiency virus type 1-specific CD8+ T-lymphocyte responses in blood and mucosa during chronic infection","volume":"79","author":"Ibarrondo","year":"2005","journal-title":"J. Virol."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1089\/088282403771926274","article-title":"Mucosal AIDS vaccines","volume":"16","author":"Bourinbaiar","year":"2003","journal-title":"Viral Immunol."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1128\/JVI.79.1.393-400.2005","article-title":"CD8+ T-cell-mediated cross-clade protection in the genital tract following intranasal immunization with inactivated human immunodeficiency virus antigen plus CpG oligodeoxynucleotides","volume":"79","author":"Jiang","year":"2005","journal-title":"J. Virol."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/0264-410X(94)90112-0","article-title":"New strategies for using mucosal vaccination to achieve more effective immunization","volume":"12","author":"Walker","year":"1994","journal-title":"Vaccine"},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"1775","DOI":"10.1016\/S0264-410X(98)00441-1","article-title":"Killed whole bacterial cells, a mucosal delivery system for the induction of immunity in the respiratory tract and middle ear: an overview","volume":"17","author":"Kyd","year":"1999","journal-title":"Vaccine"},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/S0168-1656(00)00302-3","article-title":"Identifying vaccine antigens and assessing delivery systems for the prevention of bacterial infections","volume":"83","author":"Kyd","year":"2000","journal-title":"J. Biotechnol."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"2513","DOI":"10.1016\/S0264-410X(00)00481-3","article-title":"Vaccines and mucosal immunisation","volume":"19","author":"Cripps","year":"2001","journal-title":"Vaccine"},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"2261","DOI":"10.1097\/00002030-199817000-00006","article-title":"Live attenuated simian immunodeficiency virus (SIV)mac in macaques can induce protection against mucosal infection with SIVsm","volume":"12","author":"Nilsson","year":"1998","journal-title":"AIDS (London, England)"},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"8762","DOI":"10.1128\/JVI.74.18.8762-8766.2000","article-title":"Induction of mucosal homing virus-specific CD8(+) T lymphocytes by attenuated simian immunodeficiency virus","volume":"74","author":"Cromwell","year":"2000","journal-title":"J. Virol."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"3017","DOI":"10.1073\/pnas.0308677101","article-title":"Early protection against pathogenic virus infection at a mucosal challenge site after vaccination with attenuated simian immunodeficiency virus","volume":"101","author":"Uberla","year":"2004","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"5009","DOI":"10.1016\/j.vaccine.2005.05.032","article-title":"Mucosally-administered human-simian immunodeficiency virus DNA and fowlpoxvirus-based recombinant vaccines reduce acute phase viral replication in macaques following vaginal challenge with CCR5-tropic SHIVSF162P3","volume":"23","author":"Kent","year":"2005","journal-title":"Vaccine"},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"6209","DOI":"10.4049\/jimmunol.172.10.6209","article-title":"Induction of HIV immunity in the genital tract after intranasal delivery of a MVA vector: enhanced immunogenicity after DNA prime-modified vaccinia virus Ankara boost immunization schedule","volume":"172","author":"Gherardi","year":"2004","journal-title":"J. Immunol."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1089\/0889222041725253","article-title":"An SHIV DNA\/MVA rectal vaccination in macaques provides systemic and mucosal virus-specific responses and protection against AIDS","volume":"20","author":"Wang","year":"2004","journal-title":"AIDS Res. Hum. Retroviruses"},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"2678","DOI":"10.1128\/JVI.79.5.2678-2688.2005","article-title":"Recombinant modified vaccinia virus Ankara expressing the spike glycoprotein of severe acute respiratory syndrome coronavirus induces protective neutralizing antibodies primarily targeting the receptor binding region","volume":"79","author":"Chen","year":"2005","journal-title":"J. Virol."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"6641","DOI":"10.1073\/pnas.0401939101","article-title":"Severe acute respiratory syndrome coronavirus spike protein expressed by attenuated vaccinia virus protectively immunizes mice","volume":"101","author":"Bisht","year":"2004","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1016\/S0264-410X(99)00278-9","article-title":"Gene gun intradermal DNA immunization followed by boosting with modified vaccinia virus Ankara: enhanced CD8+ T cell immunogenicity and protective efficacy in the influenza and malaria models","volume":"18","author":"Degano","year":"1999","journal-title":"Vaccine"},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"1032","DOI":"10.1016\/0264-410X(94)90341-7","article-title":"A recombinant vector derived from the host range-restricted and highly attenuated MVA strain of vaccinia virus stimulates protective immunity in mice to influenza virus","volume":"12","author":"Sutter","year":"1994","journal-title":"Vaccine"},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.vaccine.2004.05.015","article-title":"Protective and disease-enhancing immune responses induced by recombinant modified vaccinia Ankara (MVA) expressing respiratory syncytial virus proteins","volume":"23","author":"Olszewska","year":"2004","journal-title":"Vaccine"},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1016\/j.vaccine.2003.10.010","article-title":"Vaccination of infant macaques with a recombinant modified vaccinia virus Ankara expressing the respiratory syncytial virus F and G genes does not predispose for immunopathology","volume":"22","author":"Wyatt","year":"2004","journal-title":"Vaccine"},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1016\/S0264-410X(99)00257-1","article-title":"Priming and boosting immunity to respiratory syncytial virus by recombinant replication-defective vaccinia virus MVA","volume":"18","author":"Wyatt","year":"1999","journal-title":"Vaccine"},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"5386","DOI":"10.4049\/jimmunol.167.9.5386","article-title":"Cytokine requirements for induction of systemic and mucosal CTL after nasal immunization","volume":"167","author":"Staats","year":"2001","journal-title":"J. Immunol."},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"3745","DOI":"10.4049\/jimmunol.172.6.3745","article-title":"Control of simian\/human immunodeficiency virus viremia and disease progression after IL-2-augmented DNA-modified vaccinia virus Ankara nasal vaccination in nonhuman primates","volume":"172","author":"Bertley","year":"2004","journal-title":"J. Immunol."},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"2407","DOI":"10.1099\/vir.0.79869-0","article-title":"Enhanced cellular immunity and systemic control of SHIV infection by combined parenteral and mucosal administration of a DNA prime MVA boost vaccine regimen","volume":"85","author":"Makitalo","year":"2004","journal-title":"J. Gen. Virol."},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1126\/science.292.5514.69","article-title":"Control of a mucosal challenge and prevention of AIDS by a multiprotein DNA\/MVA vaccine","volume":"292","author":"Amara","year":"2001","journal-title":"Science"},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"6216","DOI":"10.1016\/j.vaccine.2006.05.094","article-title":"Safety and immunogenicity of attenuated Salmonella enterica serovar Typhimurium delivering an HIV-1 Gag antigen via the Salmonella Type III secretion system","volume":"24","author":"Kotton","year":"2006","journal-title":"Vaccine"},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1586\/14760584.6.3.431","article-title":"Live-attenuated Salmonella as a prototype vaccine vector for passenger immunogens in humans: are we there yet?","volume":"6","author":"Lewis","year":"2007","journal-title":"Expert Rev. Vaccines"},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"e4180:1","DOI":"10.1371\/journal.pone.0004180","article-title":"A novel replication-competent vaccinia vector MVTT is superior to MVA for inducing high levels of neutralizing antibody via mucosal vaccination","volume":"4","author":"Huang","year":"2009","journal-title":"PLoS One"},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"3066","DOI":"10.1002\/(SICI)1521-4141(199810)28:10<3066::AID-IMMU3066>3.0.CO;2-2","article-title":"Homing of mononuclear cells from iliac lymph nodes to the genital and rectal mucosa in non-human primates","volume":"28","author":"Mitchell","year":"1998","journal-title":"Eur. J. Immunol."},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1172\/JCI20261","article-title":"Transcutaneous immunization induces mucosal CTLs and protective immunity by migration of primed skin dendritic cells","volume":"113","author":"Belyakov","year":"2004","journal-title":"J. Clin. Invest."},{"key":"ref_80","doi-asserted-by":"crossref","unstructured":"Yu, W., Fang, Q., Zhu, W., Wang, H., Tien, P., Zhang, L., and Chen, Z. (2009). One time intranasal vaccination with a modified vaccinia Tiantan strain MVTTZCI protects animals against pathogenic viral challenge. Vaccine.","DOI":"10.1016\/j.vaccine.2009.12.038"},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1038\/nature07469","article-title":"Immune control of an SIV challenge by a T-cell-based vaccine in rhesus monkeys","volume":"457","author":"Liu","year":"2009","journal-title":"Nature"},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"2209","DOI":"10.1056\/NEJMoa0908492","article-title":"Vaccination with ALVAC and AIDSVAX to prevent HIV-1 infection in Thailand","volume":"361","author":"Pitisuttithum","year":"2009","journal-title":"N. Engl. J. Med."}],"container-title":["Viruses"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1999-4915\/2\/1\/283\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T22:01:18Z","timestamp":1760220078000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1999-4915\/2\/1\/283"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,1,22]]},"references-count":82,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2010,1]]}},"alternative-id":["v2010283"],"URL":"https:\/\/doi.org\/10.3390\/v2010283","relation":{},"ISSN":["1999-4915"],"issn-type":[{"type":"electronic","value":"1999-4915"}],"subject":[],"published":{"date-parts":[[2010,1,22]]}}}